Angiographic methods to assess human coronary angiogenesis

被引:55
作者
Gibson, CM
Ryan, K
Sparano, A
Moynihan, JL
Rizzo, M
Kelley, M
Marble, SJ
Laham, R
Simons, M
McClusky, TR
Dodge, JT
机构
[1] Allegheny Gen Hosp, Dept Med, Div Cardiovasc, Pittsburgh, PA 15143 USA
[2] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[3] Beth Israel Hosp, Dept Med, Div Cardiovasc, Boston, MA 02215 USA
[4] Genentech Inc, Dept Med, Div Cardiovasc, Boston, MA USA
关键词
D O I
10.1016/S0002-8703(99)70473-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is unclear how agents designed to promote angiogenesis in the human heart affect the arteriographic appearance of the collateral circulation. Possible changes in collateral vessels include new collateral vessels arising from epicardial arteries, new branches emanating from existing collateral vessels, wider or longer collateral vessels, and higher dye transit rates that result in improved recipient vessel filling. Given the multiple mechanisms by which these new agents may improve myocardial perfusion, a rigorous, systematic, and comprehensive analysis of coronary arteriograms is required to discern the true mechanism of benefit. The method of analysis must account for potential changes in collateral blood flow, number, branching pat tern, and length as well as changes in recipient vessel filling. The ability to detect differences between intricate networks of vessels in an angiographic study is dependent on maintaining consistency in cinefilming as well as the core laboratory methods between time points. In this report, we describe the methodology our angiographic core laboratory has found to be most effective to evaluate these very complex angiograms and attempt to capture all the possible modalities of angiogenesis.
引用
收藏
页码:169 / 179
页数:11
相关论文
共 25 条
  • [21] Induction of neoangiogenesis in ischemic myocardium by human growth factors - First clinical results of a new treatment of coronary heart disease
    Schumacher, B
    Pecher, P
    von Specht, BU
    Stegmann, T
    [J]. CIRCULATION, 1998, 97 (07) : 645 - 650
  • [22] TEMPORAL EVOLUTION OF THE HUMAN CORONARY COLLATERAL CIRCULATION AFTER MYOCARDIAL-INFARCTION
    SCHWARTZ, H
    LEIBOFF, RH
    BREN, GB
    WASSERMAN, AG
    KATZ, RJ
    VARGHESE, PJ
    SOKIL, AB
    ROSS, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 4 (06) : 1088 - 1093
  • [23] PRESERVATION OF LEFT-VENTRICULAR FUNCTION IN PATIENTS WITH TOTAL OCCLUSION OF THE LEFT ANTERIOR DESCENDING CORONARY-ARTERY AND WIDE-CALIBER DISTAL VESSEL FILLING BY COLLATERAL VASCULATURE
    SEDLIS, SP
    COHEN, KH
    SEQUEIRA, JM
    ELSHERIF, N
    [J]. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1988, 15 (03): : 139 - 142
  • [24] THE EFFECT OF INTRAVENOUS THROMBOLYTIC THERAPY ON LEFT-VENTRICULAR FUNCTION - A REPORT ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE FROM THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI PHASE-I) TRIAL
    SHEEHAN, FH
    BRAUNWALD, E
    CANNER, P
    DODGE, HT
    GORE, J
    VANNATTA, P
    PASSAMANI, ER
    WILLIAMS, DO
    ZARET, B
    [J]. CIRCULATION, 1987, 75 (04) : 817 - 829
  • [25] SALVAGE OF INFARCTED MYOCARDIUM BY ANGIOGENIC ACTION OF BASIC FIBROBLAST GROWTH-FACTOR
    YANAGISAWAMIWA, A
    UCHIDA, Y
    NAKAMURA, F
    TOMARU, T
    KIDO, H
    KAMIJO, T
    SUGIMOTO, T
    KAJI, K
    UTSUYAMA, M
    KURASHIMA, C
    ITO, H
    [J]. SCIENCE, 1992, 257 (5075) : 1401 - 1403